Roche Says Drug Helped Patients Reduce Blood-Sugar Levels, Weight in Trial

The results for enicepatide reinforce the company's ambitions to rapidly develop its portfolio of medicines for people with obesity, diabetes and cardiovascular disease.

本文内容来自外部来源，点击「继续访问」将跳转到原始发布站点。